10-Hz Modulation Laser Acupuncture Induced Specific Cerebral Cortical Activations

Hsieh, C-W; Hsieh, C-H; Jh, Wu; Wang, O-F; Jh, Chen

doi:10.1016/s1053-8119(09)70288-5

Cited by 1 publication

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Because the incidence and severity of CINV were similar between the groups in the current study, differences in nausea and vomiting cannot explain the QOL differences noted on day 4. According to recent research, K1 acupuncture stimulation can induce cerebral cortical activation, affecting memory, attention, and self‐consciousness as assessed through functional magnetic resonance imaging . Although to our knowledge no systematic research to date has been conducted on K1 stimulation, it is widely used for the treatment of symptoms such as insomnia, headache, fever, buccal ulceration, and dizziness, all of which are common in patients with cancer after chemotherapy and can affect QOL.…”

Section: Discussionmentioning

confidence: 99%

“…According to recent research, K1 acupuncture stimulation can induce cerebral cortical activation, affecting memory, attention, and self-consciousness as assessed through functional magnetic resonance imaging. 38 Although to our knowledge no systematic research to date has been conducted on K1 stimulation, it is widely used for the treatment of symptoms such as insomnia, headache, fever, buccal ulceration, and dizziness, all of which are common in patients with cancer after chemotherapy and can affect QOL. Although highly speculative, improvements in EuroQoL scores may be related to control of the above symptoms.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Randomized, placebo‐controlled trial of K1 acupoint acustimulation to prevent cisplatin‐induced or oxaliplatin‐induced nausea

Shen

Liu

Chiang

et al. 2014

Cancer

View full text Add to dashboard Cite

Background More than 70% of cancer patients experience chemotherapy-induced nausea and vomiting (CINV). We examined the effects of electrostimulation of the K1 acupoint located on the sole of the foot, as it is thought to have potential to control CINV. Methods In this trial, 103 patients diagnosed with primary or metastatic liver cancer were recruited before trans-catheter arterial infusion (TAI) of cisplatin (CDDP) or oxaliplatin (OXA) and randomized to group A (N=51; treated with the antiemetic tropisetron and acustimulation at the K1 acupoint for 20 minutes, 1-2 hours before TAI on the first day and then daily for the subsequent 5 days) or group B (N=53; treated with tropisetron and electrostimulation at a placebo point on the heel). The rate, intensity, and duration of nausea and vomiting were collected at baseline and then daily for 5 days after TAI. Quality of life was assessed daily using the MD Anderson Symptom Inventory (MDASI) and the EuroQoL scale. Results No differences were found between groups A and B in the incidence and degree of nausea or vomiting on day 1 or the consecutive 5 days. Patients in group A had better EuroQoL scores than did patients in group B (A: 72.83 versus B: 65.94, P = 0.04) on day 4 but not on the other days. No group differences were noted at any time point for MDASI scores. Conclusions Electrostimulation of K1 combined with antiemetics did not result in initial prevention of CDDP- or OXA-induced nausea or vomiting.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%